Company / Net Income
Rani Therapeutics Holdings, Inc. Net Income History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$30.0M
FY2025
5-year range
-$34.0M / -$8.3M
FY2021-FY2025
Trend
+11.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -$8M to -$30M over the past 3 years.
Based on SEC 10-K filings.
-$30M in FY2025.
Declined from -$8M to -$30M over the past 3 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, net income increased 11.6% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$30.0M | +11.6% |
| FY2024 | -$34.0M | -307.8% |
| FY2022 | -$8.3M | +0.0% |
| FY2021 | -$8.3M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026